Halozyme Therapeutics, Inc. (MM) News - HALO

Best deals to access real time data!
SMALL CAP PRO
Monthly Subscription
for only
$44.59
Canadian Level 1 + USA
Monthly Subscription
for only
$34.59
ULTIMATE TRADER
Monthly Subscription
for only
$72.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Halozyme Therapeutics, Inc. (MM) HALO NASDAQ Common Stock US40637H1095
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0 +0% 13.53 - - - 13.53 08:00:07
more quote information »
Industry Sector
Biotechnology

Recent News

Date Time Source Heading
7/26/201717:29EDGARStatement of Changes in Beneficial Ownership (4)
7/26/201717:25EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
7/13/201708:30PRNUSInitiation Of Clinical Trial Collaboration Evaluating..
7/10/201716:15PRNUSHalozyme To Host Second Quarter 2017 Financial Results..
7/05/201716:07EDGARCurrent Report Filing (8-k)
6/28/201712:00PRNUSHalozyme Phase 2 Data In Advanced Pancreas Cancer Presented..
6/22/201715:16PRNUSFDA Approves Genentech's RITUXAN HYCELA, A Subcutaneous..
6/16/201716:12EDGARStatement of Changes in Beneficial Ownership (4)
6/04/201711:45PRNUSHalozyme Phase 2 Data In Advanced Pancreas Cancer Featured..
5/25/201716:05PRNUSHalozyme Therapeutics To Present At Upcoming Healthcare..
5/24/201716:05PRNUSHalozyme Therapeutics Announces Completion Of Public..
5/19/201717:13EDGARCurrent Report Filing (8-k)
5/19/201717:08EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/18/201721:25PRNUSHalozyme Therapeutics Prices Public Offering Of Common Stock
5/18/201716:05PRNUSHalozyme Therapeutics Announces Public Offering Of Common..
5/18/201716:03EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/17/201717:29PRNUSHalozyme Phase 2 Data In Advanced Pancreas Cancer To Be..
5/15/201709:11EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201718:01EDGARStatement of Changes in Beneficial Ownership (4)
5/09/201716:26EDGARQuarterly Report (10-q)
5/09/201716:21EDGARCurrent Report Filing (8-k)
5/09/201716:12EDGARCurrent Report Filing (8-k)
5/09/201716:05PRNUSHalozyme Reports First Quarter 2017 Financial Results
5/08/201716:02EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201717:00EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:59EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:58EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:58EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:55EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:54EDGARStatement of Changes in Beneficial Ownership (4)
5/05/201716:12EDGARCurrent Report Filing (8-k)
4/14/201714:04EDGARStatement of Changes in Beneficial Ownership (4)
4/10/201716:15PRNUSHalozyme To Host First Quarter 2017 Financial Results..
4/03/201708:00PRNUSHalozyme's PEGPH20 Increases Immune Response and..
3/30/201708:30PRNUSHalozyme Provides Update On SWOG Collaborative Group..
3/29/201712:44PRNUSFDA Advisory Committee Provides Unanimous Recommendation For..
3/24/201716:14EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/24/201716:09EDGARProxy Statement (definitive) (def 14a)
2/28/201716:05PRNUSHalozyme Reports Fourth Quarter And Full Year 2016 Financial..
2/24/201716:09EDGARStatement of Changes in Beneficial Ownership (4)
2/24/201716:09EDGARStatement of Changes in Beneficial Ownership (4)
2/24/201716:08EDGARStatement of Changes in Beneficial Ownership (4)
2/24/201716:06EDGARStatement of Changes in Beneficial Ownership (4)
2/24/201716:06EDGARStatement of Changes in Beneficial Ownership (4)
2/23/201716:30PRNUSHalozyme Therapeutics To Present At Upcoming Healthcare..
2/14/201714:56EDGARAmended Statement of Ownership (sc 13g/a)
2/14/201711:28EDGARStatement of Ownership (sc 13g)
2/13/201709:52EDGARAmended Statement of Ownership (sc 13g/a)
2/13/201708:30PRNUSMabVax Therapeutics Studies Lead Investigational Drug..
2/07/201716:41EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.